L’achèvement de l’étude marque une étape importante dans le programme européen de l’entreprise SAN JOSE, Californie, 25 avril 2024 /PRNewswire/ — Lykos Therapeutics (anciennement MAPS Public Benefit Corporation) (« Lykos »), une société dédiée à la transformation des soins de santé…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.